Search by Drug Name or NDC

    NDC 75834-0203-01 GLYBURIDE 2.5 mg/1 Details

    GLYBURIDE 2.5 mg/1

    GLYBURIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nivagen Pharmaceuticals, Inc.. The primary component is GLYBURIDE.

    Product Information

    NDC 75834-0203
    Product ID 75834-203_757b12d9-8efb-49ca-b8f7-7884535ca011
    Associated GPIs 27200040000310
    GCN Sequence Number 001774
    GCN Sequence Number Description glyburide TABLET 2.5 MG ORAL
    HIC3 C4K
    HIC3 Description ANTIHYPERGLYCEMIC, INSULIN-RELEASE STIMULANT TYPE
    GCN 05711
    HICL Sequence Number 000802
    HICL Sequence Number Description GLYBURIDE
    Brand/Generic Generic
    Proprietary Name GLYBURIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name GLYBURIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name GLYBURIDE
    Labeler Name Nivagen Pharmaceuticals, Inc.
    Pharmaceutical Class Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203379
    Listing Certified Through 2024-12-31

    Package

    NDC 75834-0203-01 (75834020301)

    NDC Package Code 75834-203-01
    Billing NDC 75834020301
    Package 100 TABLET in 1 BOTTLE (75834-203-01)
    Marketing Start Date 2019-01-25
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.07803
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description GLYBURIDE 2.5 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 43c6f68b-5747-47c6-9538-51ef8c611db4 Details

    Revised: 1/2021